Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Haplotype block analysis of an Argentinean hexaploid wheat collection and GWAS for yield components and adaptation.

Luján Basile SM, Ramírez IA, Crescente JM, Conde MB, Demichelis M, Abbate P, Rogers WJ, Pontaroli AC, Helguera M, Vanzetti LS.

BMC Plant Biol. 2019 Dec 16;19(1):553. doi: 10.1186/s12870-019-2015-4.

2.

Evaluating the disease and treatment information provided to patients with chronic obstructive pulmonary disease at the time of discharge according to GOLD discharge guidelines.

Morais LA, Cavalcante SYIES, Conde MB, Rabahi MF.

Einstein (Sao Paulo). 2019 Dec 9;18:eAO4706. doi: 10.31744/einstein_journal/2020AO4706. eCollection 2020. English, Portuguese.

3.

Characterization and comparison of strains of Pasteurella multocida associated with cases of progressive atrophic rhinitis and porcine pneumonia in Argentina.

Bessone FA, Pérez MLS, Zielinski G, Dibarbora M, Conde MB, Cappuccio J, Alustiza F.

Vet World. 2019;12(3):434-439. doi: 10.14202/vetworld.2019.434-439. Epub 2019 Mar 21.

4.

Social determinants of pulmonary tuberculosis in Brazil: an ecological study.

Zille AI, Werneck GL, Luiz RR, Conde MB.

BMC Pulm Med. 2019 May 8;19(1):87. doi: 10.1186/s12890-019-0855-1.

5.

Impact of smoking on sputum culture conversion and pulmonary tuberculosis treatment outcomes in Brazil: a retrospective cohort study.

Cailleaux-Cezar M, Loredo C, Silva JRLE, Conde MB.

J Bras Pneumol. 2018 Apr;44(2):99-105. doi: 10.1590/s1806-37562017000000161. Portuguese, English.

6.

Tuberculosis treatment.

Rabahi MF, Silva Júnior JLRD, Ferreira ACG, Tannus-Silva DGS, Conde MB.

J Bras Pneumol. 2017 Nov-Dec;43(6):472-486. doi: 10.1590/S1806-37562016000000388. Review. English, Portuguese. Erratum in: J Bras Pneumol. 2018 Jul-Sep;44(4):340.

7.

Evaluation of the impact that the changes in tuberculosis treatment implemented in Brazil in 2009 have had on disease control in the country.

Rabahi MF, Silva Júnior JLRD, Conde MB.

J Bras Pneumol. 2017 Nov-Dec;43(6):437-444. doi: 10.1590/S1806-37562017000000004. English, Portuguese.

8.

Presence and characterization of Escherichia coli virulence genes isolated from diseased pigs in the central region of Argentina.

Bessone FA, Bessone G, Marini S, Conde MB, Alustiza FE, Zielinski G.

Vet World. 2017 Aug;10(8):939-945. doi: 10.14202/vetworld.2017.939-945. Epub 2017 Aug 18.

9.

Sleep-disordered breathing in patients with COPD and mild hypoxemia: prevalence and predictive variables.

Silva JLR Júnior, Conde MB, Corrêa KS, Rabahi H, Rocha AA, Rabahi MF.

J Bras Pneumol. 2017 May-Jun;43(3):176-182. doi: 10.1590/S1806-37562016000000051. English, Portuguese.

10.

Myocardial performance index correlates with the BODE index and affects quality of life in COPD patients.

Tannus-Silva DG, Masson-Silva JB, Ribeiro LS, Conde MB, Rabahi MF.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 16;11:2261-2268. eCollection 2016.

11.

A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis.

Conde MB, Mello FC, Duarte RS, Cavalcante SC, Rolla V, Dalcolmo M, Loredo C, Durovni B, Armstrong DT, Efron A, Barnes GL, Marzinke MA, Savic RM, Dooley KE, Cohn S, Moulton LH, Chaisson RE, Dorman SE.

PLoS One. 2016 May 9;11(5):e0154778. doi: 10.1371/journal.pone.0154778. eCollection 2016.

12.

Prevalence of chronic obstructive pulmonary disease among patients with systemic arterial hypertension without respiratory symptoms.

Rabahi MF, Pereira SA, Silva Júnior JL, de Rezende AP, Castro da Costa A, de Sousa Corrêa K, Conde MB.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 31;10:1525-9. doi: 10.2147/COPD.S85588. eCollection 2015.

13.

Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.

Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group; Tuberculosis Trials Consortium.

JAMA Pediatr. 2015 Mar;169(3):247-55. doi: 10.1001/jamapediatrics.2014.3158. Erratum in: JAMA Pediatr. 2015 Sep;169(9):878.

14.

COPD Assessment Test (CAT) score as a predictor of major depression among subjects with chronic obstructive pulmonary disease and mild hypoxemia: a case-control study.

Silva Júnior JL, Conde MB, de Sousa Corrêa K, da Silva C, da Silva Prestes L, Rabahi MF.

BMC Pulm Med. 2014 Nov 28;14:186. doi: 10.1186/1471-2466-14-186.

15.

Active case finding of tuberculosis (TB) in an emergency room in a region with high prevalence of TB in Brazil.

Silva DR, Müller AM, Tomasini Kda S, Dalcin Pde T, Golub JE, Conde MB.

PLoS One. 2014 Sep 11;9(9):e107576. doi: 10.1371/journal.pone.0107576. eCollection 2014.

16.

Yield of close contact tracing using two different programmatic approaches from tuberculosis index cases: a retrospective quasi-experimental study.

Loredo C, Cailleaux-Cezar M, Efron A, de Mello FC, Conde MB.

BMC Pulm Med. 2014 Aug 7;14:133. doi: 10.1186/1471-2466-14-133.

17.

Understanding and retention of trial-related information among participants in a clinical trial after completing the informed consent process.

Mexas F, Efron A, Luiz RR, Cailleaux-Cezar M, Chaisson RE, Conde MB.

Clin Trials. 2014 Feb;11(1):70-6. doi: 10.1177/1740774513509316. Epub 2013 Dec 2.

PMID:
24296322
18.

Cost-effectiveness of routine diagnostic evaluation of pulmonary tuberculosis in a primary care unit in Brazil.

Guerra RL, Dorman SE, Luiz RR, Conde MB.

Int J Tuberc Lung Dis. 2013 Oct;17(10):1336-40. doi: 10.5588/ijtld.13.0073.

PMID:
24025387
20.

Prevalence of primary drug resistance in pulmonary tuberculosis patients with no known risk factors for such.

Bastos GM, Cezar MC, Mello FC, Conde MB.

J Bras Pneumol. 2012 Nov-Dec;38(6):733-9. English, Portuguese.

21.
22.

Time from symptom onset to the initiation of treatment of pulmonary tuberculosis in a city with a high incidence of the disease.

Maior Mde L, Guerra RL, Cailleaux-Cezar M, Golub JE, Conde MB.

J Bras Pneumol. 2012 Mar-Apr;38(2):202-9. English, Portuguese.

23.
24.

Three months of rifapentine and isoniazid for latent tuberculosis infection.

Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team.

N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875.

25.

Evaluation of real-time PCR of patient pleural effusion for diagnosis of tuberculosis.

Rosso F, Michelon CT, Sperhacke RD, Verza M, Olival L, Conde MB, Guerra RL, Zaha A, Rossetti ML.

BMC Res Notes. 2011 Aug 5;4:279. doi: 10.1186/1756-0500-4-279.

26.

Determination of levels of specific IgA to the HspX recombinant antigen of Mycobacterium tuberculosis for the diagnosis of pleural tuberculosis.

Limongi LC, Olival L, Conde MB, Junqueira-Kipnis AP.

J Bras Pneumol. 2011 May-Jun;37(3):302-7. English, Portuguese.

27.

Effect of continuous positive airway pressure on fluid absorption among patients with pleural effusion due to tuberculosis.

Oliveira JF, Mello FC, Rodrigues RS, Boechat AL, Conde MB, Menezes SL.

Rev Bras Fisioter. 2010 Mar-Apr;14(2):127-32. Epub 2010 Apr 30.

PMID:
20464170
28.

Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.

Guerra RL, Conde MB, Efron A, Loredo C, Bastos G, Chaisson RE, Golub JE.

Respir Med. 2010 May;104(5):754-7. doi: 10.1016/j.rmed.2010.02.001. Epub 2010 Mar 3.

29.

III Brazilian Thoracic Association Guidelines on tuberculosis.

Conde MB, Melo FA, Marques AM, Cardoso NC, Pinheiro VG, Dalcin Pde T, Machado Junior A, Lemos AC, Netto AR, Durovni B, Sant'Anna CC, Lima D, Capone D, Barreira D, Matos ED, Mello FC, David FC, Marsico G, Afiune JB, Silva JR, Jamal LF, Telles MA, Hirata MH, Dalcolmo MP, Rabahi MF, Cailleaux-Cesar M, Palaci M, Morrone N, Guerra RL, Dietze R, Miranda SS, Cavalcante SC, Nogueira SA, Nonato TS, Martire T, Galesi VM, Dettoni Vdo V; BTA Committee on Tuberculosis; BTA Guidelines on Tuberculosis Work Group.

J Bras Pneumol. 2009 Oct;35(10):1018-48. Review. English, Portuguese.

30.

Prolonged recruitment manoeuvre improves lung function with less ultrastructural damage in experimental mild acute lung injury.

Rzezinski AF, Oliveira GP, Santiago VR, Santos RS, Ornellas DS, Morales MM, Capelozzi VL, Amato MB, Conde MB, Pelosi P, Rocco PR.

Respir Physiol Neurobiol. 2009 Dec 31;169(3):271-81. doi: 10.1016/j.resp.2009.10.002. Epub 2009 Oct 9.

PMID:
19819351
31.

Intermittent treatment for TB and resistance.

Conde MB.

J Bras Pneumol. 2009 Jun;35(6):497-9. English, Portuguese. No abstract available.

32.

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.

Conde MB, Efron A, Loredo C, De Souza GR, Graça NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, Chaisson RE.

Lancet. 2009 Apr 4;373(9670):1183-9. doi: 10.1016/S0140-6736(09)60333-0.

33.

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

Ribeiro S, Dooley K, Hackman J, Loredo C, Efron A, Chaisson RE, Conde MB, Boechat N, Dorman SE.

BMC Infect Dis. 2009 Feb 28;9:23. doi: 10.1186/1471-2334-9-23.

34.

Tuberculosis incidence among contacts of active pulmonary tuberculosis.

Cailleaux-Cezar M, de A Melo D, Xavier GM, de Salles CL, de Mello FC, Ruffino-Netto A, Golub JE, Efron A, Chaisson RE, Conde MB.

Int J Tuberc Lung Dis. 2009 Feb;13(2):190-5.

35.

Cost-effectiveness of different strategies for amplified Mycobacterium tuberculosis direct testing for cases of pulmonary tuberculosis.

Guerra RL, Hooper NM, Baker JF, Alborz R, Armstrong DT, Kiehlbauch JA, Conde MB, Dorman SE.

J Clin Microbiol. 2008 Nov;46(11):3811-2. doi: 10.1128/JCM.01682-08. Epub 2008 Sep 17.

36.

Humoral response to HspX and GlcB to previous and recent infection by Mycobacterium tuberculosis.

Rabahi MF, Junqueira-Kipnis AP, Dos Reis MC, Oelemann W, Conde MB.

BMC Infect Dis. 2007 Dec 31;7:148. doi: 10.1186/1471-2334-7-148.

37.

Specimen dilution improves sensitivity of the amplified Mycobacterium tuberculosis direct test for smear microscopy-positive respiratory specimens.

Guerra RL, Baker JF, Alborz R, Armstrong DT, Kiehlbauch JA, Conde MB, Dorman SE, Hooper NM.

J Clin Microbiol. 2008 Jan;46(1):314-6. Epub 2007 Oct 31.

38.

Peculiarities of tuberculosis control in a scenario of urban violence in a disadvantaged community in Rio de Janeiro, Brazil.

Souza FB, Villa TC, Cavalcante SC, Ruffino Netto A, Lopes LB, Conde MB.

J Bras Pneumol. 2007 May-Jun;33(3):318-22. English, Portuguese.

39.

Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.

Szklo A, Mello FC, Guerra RL, Dorman SE, Muzy-de-Souza GR, Conde MB.

Int J Tuberc Lung Dis. 2007 Jul;11(7):775-80.

PMID:
17609053
40.

The presence of a booster phenomenon among contacts of active pulmonary tuberculosis cases: a retrospective cohort.

Salles CG, Ruffino-Netto A, Lapa-e-Silva JR, Kritski AL, Cailleaux-Cesar M, Queiroz-Mello FC, Conde MB.

BMC Public Health. 2007 Mar 19;7:38.

41.

[Tuberculous pleural effusions].

Seiscento M, Conde MB, Dalcolmo MM.

J Bras Pneumol. 2006;32 Suppl 4:S174-81. Portuguese.

42.

Prevalence of pulmonary tuberculosis among respiratory symptomatic subjects in an out-patient primary health unit.

Bastos LG, Fonseca LS, Mello FC, Ruffino-Netto A, Golub JE, Conde MB.

Int J Tuberc Lung Dis. 2007 Feb;11(2):156-60. Erratum in: Int J Tuberc Lung Dis. 2007 Aug;11(8):936. Golub, J L [corrected to Golub, J E].

PMID:
17263285
43.

Evaluation of a proposed diagnostic scoring system for pulmonary tuberculosis in Brazilian children.

Sant'Anna CC, Orfaliais CT, March Mde F, Conde MB.

Int J Tuberc Lung Dis. 2006 Apr;10(4):463-5.

PMID:
16602415
44.

Predicting smear negative pulmonary tuberculosis with classification trees and logistic regression: a cross-sectional study.

Mello FC, Bastos LG, Soares SL, Rezende VM, Conde MB, Chaisson RE, Kritski AL, Ruffino-Netto A, Werneck GL.

BMC Public Health. 2006 Feb 23;6:43.

45.

Defaulting from anti-tuberculosis treatment in a teaching hospital in Rio de Janeiro, Brazil.

Salles CL, Conde MB, Hofer C, Cunha AJ, Calçada AL, Menezes DF, Sá L, Kritski AL.

Int J Tuberc Lung Dis. 2004 Mar;8(3):318-22.

PMID:
15139470
46.
47.

The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10.

Huard RC, Chitale S, Leung M, Lazzarini LC, Zhu H, Shashkina E, Laal S, Conde MB, Kritski AL, Belisle JT, Kreiswirth BN, Lapa e Silva JR, Ho JL.

Infect Immun. 2003 Dec;71(12):6871-83.

48.

Yield of sputum induction in the diagnosis of pleural tuberculosis.

Conde MB, Loivos AC, Rezende VM, Soares SL, Mello FC, Reingold AL, Daley CL, Kritski AL.

Am J Respir Crit Care Med. 2003 Mar 1;167(5):723-5.

PMID:
12598215
49.

Serologic diagnosis of tuberculosis using a simple commercial multiantigen assay.

Perkins MD, Conde MB, Martins M, Kritski AL.

Chest. 2003 Jan;123(1):107-12.

PMID:
12527610
50.

The usefulness of serum adenosine deaminase 2 (ADA2) activity in adults for the diagnosis of pulmonary tuberculosis.

Conde MB, Marinho SR, Pereira Mde F, Lapa e Silva JR, Saad MH, Sales CL, Ho JL, Kritski AL.

Respir Med. 2002 Aug;96(8):607-10.

Supplemental Content

Loading ...
Support Center